VSTM vs. CNTA
VSTM (Verastem, Inc.) and CNTA (Centessa Pharmaceuticals Limited) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
VSTM vs. CNTA - Performance Comparison
Loading charts...
Returns By Period
VSTM
- 1D
- -4.92%
- 1M
- 28.89%
- 6M
- -4.92%
- YTD
- -24.87%
- 1Y
- -4.61%
- 3Y*
- -19.16%
- 5Y*
- -31.61%
- 10Y*
- -9.76%
- ALL TIME*
- -19.38%
CNTA
- 1D
- —
- 1M
- —
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
VSTM Verastem, Inc. | $12.13M | $14.17M | $12.30M |
VSTM vs. CNTA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
VSTM Verastem, Inc. | -24.87% | 49.32% | -36.49% | 68.53% | -80.37% | -48.75% |
CNTA Centessa Pharmaceuticals Limited | 61.94% | 49.31% | 110.43% | 156.77% | -72.47% | -44.40% |
Correlation
The correlation between VSTM and CNTA is 0.13, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.13 |
Correlation (3Y) Balances recent behavior with more history. | 0.26 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.23 |
Correlation (All Time) Calculated using the full available price history since May 28, 2021 | 0.23 |
The correlation between VSTM and CNTA shifts across timeframes, from 0.13 (1 year) to 0.26 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
VSTM:
-$2.28
CNTA:
-$1.81
VSTM:
9.97
CNTA:
362.24
VSTM:
$49.59M
CNTA:
$15.00M
VSTM:
$25.91M
CNTA:
$15.00M
VSTM:
-$209.89M
CNTA:
-$227.27M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VSTM vs. CNTA — Risk / Return Rank
VSTM
CNTA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
VSTM vs. CNTA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Verastem, Inc. (VSTM) and Centessa Pharmaceuticals Limited (CNTA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VSTM | CNTA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.05 | — | — |
| Calmar ratioReturn relative to maximum drawdown | -0.09 | — | — |
| Martin ratioReturn relative to average drawdown | -0.15 | — | — |
Loading charts...
Drawdowns
VSTM vs. CNTA - Drawdown Comparison
Loading charts...
Drawdown Indicators
| VSTM | CNTA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.96% | — | — |
Max Drawdown (1Y)Largest decline over 1 year | -67.97% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -84.36% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -94.29% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -98.16% | — | — |
Current DrawdownCurrent decline from peak | -97.25% | — | — |
Average DrawdownAverage peak-to-trough decline | -75.49% | — | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.11% | — | — |
Volatility
VSTM vs. CNTA - Volatility Comparison
Loading charts...
Volatility by Period
| VSTM | CNTA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.71% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 50.59% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 77.64% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 106.11% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 97.55% | — | — |
Dividends
VSTM vs. CNTA - Dividend Comparison
Neither VSTM nor CNTA has paid dividends to shareholders.
Financials
VSTM vs. CNTA - Financials Comparison
This section allows you to compare key financial metrics between Verastem, Inc. and Centessa Pharmaceuticals Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VSTM and CNTA have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for VSTM and CNTA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer